• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】16152

【品名】(3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol

【CA登记号】42437-96-7

【 分 子 式 】C7H13NO

【 分 子 量 】127.18636

【元素组成】C 66.11% H 10.3% N 11.01% O 12.58%

与该中间体有关的原料药合成路线共 5 条

合成路线1

该中间体在本合成路线中的序号:(V)

The alkylation of 2-phenylacetic acid (I) with 2-chloroethyl(methyl)sulfide (II) by means of lithium diisopropylamide (LDA) in THF gives 4-(methylsulfanyl)-2-phenylbutyric acid (III), which is esterified with methanol/H2SO4 yielding the methyl ester (IV). The transesterification of (IV) with quinuclidin-3(R)-ol (V) by means of NaH in refluxing toluene affords the 3(R)-quinuclidinyl ester (VI), which is hydroxymethylated with paraformaldehyde and NaH in DMF giving 2(RS)-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutyric acid 3(R)-quinuclidinyl ester (VII) as a diastereomeric mixture. Chromatographic separation of (VII) over SiO2 using CHCl3/methanol/NH4OH as a gradient elution yields the 2(S)-hydroxymethyl isomer (VIII), which is oxidized with trifluoroperacetic acid in trifluoroacetic acid affording the corresponding sulfinyl derivative (IX) as a new diastereomeric mixture. Finally, this mixture is resolved by HPLC over Kromasil C-8 SiO2 using as eluant water/acetonitrile containing 1% trifluoroacetic acid.

1 Martel, A.M.; Rabasseda, X.; Castaner, J.; Revatropate. Drugs Fut 1997, 22, 2, 135.
2 Cross, P.E.; Stobie, A. (Pfizer Inc.); Quinuclidine esters process and intermediate for their preparation and pharmaceutical compsns. containing them. EP 0603229; JP 1994510991; JP 1997315970; WO 9306098 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16148 Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid 103-82-2 C8H8O2 详情 详情
(II) 16149 2-Chloroethyl methyl sulfide; 1-Chloro-2-(methylsulfanyl)ethane 542-81-4 C3H7ClS 详情 详情
(III) 16150 4-(methylsulfanyl)-2-phenylbutyric acid C11H14O2S 详情 详情
(IV) 16151 methyl 4-(methylsulfanyl)-2-phenylbutanoate C12H16O2S 详情 详情
(V) 16152 (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol 42437-96-7 C7H13NO 详情 详情
(VI) 16153 (3R)-1-azabicyclo[2.2.2]oct-3-yl 4-(methylsulfanyl)-2-phenylbutanoate C18H25NO2S 详情 详情
(VII) 16154 (3R)-1-azabicyclo[2.2.2]oct-3-yl 2-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutanoate C19H27NO3S 详情 详情
(VIII) 16155 (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-(methylsulfanyl)-2-phenylbutanoate C19H27NO3S 详情 详情
(IX) 16156 (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-(methylsulfinyl)-2-phenylbutanoate C19H27NO4S 详情 详情

合成路线2

该中间体在本合成路线中的序号:(VII)

YM-905 has been obtained by two related ways: 1) The benzoylation of 2-phenylethylamine (I) with benzoyl chloride (II) and triethylamine in chloroform, or with benzoic acid (III), DPPA and triethylamine in DMF, gives the corresponding benzamide (IV), which is cyclized by means of POCl3 and P2O5 in refluxing xylene and reduced with NaBH4 in ethanol, yielding racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V). The reaction of (V) with ethyl chloroformate by means of K2CO3 in chloroform affords racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI), which is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to provide the quinuclidinyl ester (VIII) as a diastereomeric mixture. This mixture is resolved by chiral HPLC, giving the target compound as a pure enantiomer. 2) The racemic 1-phenyl-1,2,3,4-tetrahydroisoquinoline (V) can also be submitted to optical resolution with (+)-tartaric acid to give 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline (IX), which is condensed with ethyl chloroformate by means of K2CO3 in chloroform to afford 1(S)-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylic acid ethyl ester (VI). This compound is transesterified with quinuclidine-3(R)-ol (VII) by means of NaH in refluxing toluene to directly provide the pure enantiomer.

1 Mealy, N.; Castañer, J.; YM-905. Drugs Fut 1999, 24, 8, 871.
2 Takeuchi, M.; Naito, R.; Hayakawa, M.; Okamoto, Y.; Yonetoku, Y.; Ikeda, K.; Isomura, Y. (Yamanouchi Pharmaceutical Co., Ltd.); Novel quinuclidine derivs. and medicinal compsn. thereof. EP 0801067; US 6017927; WO 9620194 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 18333 Phenethylamine; 2-Phenyl-1-ethanamine 64-04-0 C8H11N 详情 详情
(II) 10463 Benzoyl chloride 98-88-4 C7H5ClO 详情 详情
(III) 10202 Benzoic acid 65-85-0 C7H6O2 详情 详情
(IV) 26007 N-phenethylbenzamide C15H15NO 详情 详情
(V) 26008 1-phenyl-1,2,3,4-tetrahydroisoquinoline C15H15N 详情 详情
(VI) 26009 ethyl 1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate C18H19NO2 详情 详情
(VII) 16152 (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol 42437-96-7 C7H13NO 详情 详情
(VIII) 26010 (3R)-1-azabicyclo[2.2.2]oct-3-yl 1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate C23H26N2O2 详情 详情
(IX) 26011 (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline C15H15N 详情 详情
(X) 26012 ethyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate C18H19NO2 详情 详情

合成路线3

该中间体在本合成路线中的序号:(VII)

 

1 Naito R. Yonetoku Y, Okamoto Y, et aL. 2005. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists. J Med Chem, 48(21):6597~6606
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 26007 N-phenethylbenzamide C15H15NO 详情 详情
(II) 66735 1-phenyl-3,4-dihydroisoquinoline 52250-50-7 C15H13N 详情 详情
(III) 66736 1-phenyl-1,2,3,4-tetrahydroisoquinoline   C15H15N 详情 详情
(IV) 66737     C15H15N.C4H6O6 详情 详情
(V) 26011 (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline C15H15N 详情 详情
(VI) 26012 ethyl (1S)-1-phenyl-3,4-dihydro-2(1H)-isoquinolinecarboxylate C18H19NO2 详情 详情
(VII) 16152 (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol 42437-96-7 C7H13NO 详情 详情

合成路线4

该中间体在本合成路线中的序号:(III)

 

1 Perlman N, Nidam T. 2007. Processes for preparation of solifenacin. W0 2007076116
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 26011 (1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline C15H15N 详情 详情
(II) 66739 (R)-2-chloroethyl 1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate   C18H18ClNO2 详情 详情
(III) 16152 (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol 42437-96-7 C7H13NO 详情 详情
(IV) 66740 (R)-2-chloroethyl quinuclidin-3-yl carbonate   C10H16ClNO3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(VIII)

 

1 Daeniker HU, Grob CA. 1964. 3-Quinuclidone hydrochloride. Org Syn, 44: 86~90
2 Han XY, Liu H, Liu CH, et al. 2005. Synthesis of the optical rsomers of a new anticholinergic drug, penehyclidine hydrochloride (8018). Bioorg Med Chemm lett, 15(8):1979~1982
3 Ji JG, Li T. 2005. Preparatum of bicycloheterocyclyl substituted quiniculidine derivatives for use in pharmaceutical compositions which modulate the effects of α 7 nicotinic acetylcholine receptors(α 7 nAChR). US 2005137184
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 43671 ethyl isonicotinate 1570-45-2 C8H9NO2 详情 详情
(II) 66741 1-(2-ethoxy-2-oxoethyl)-4-(ethoxycarbonyl)pyridin-1-ium bromide   C12H16BrNO4 详情 详情
(III) 66742 ethyl 1-(2-ethoxy-2-oxoethyl)piperidine-4-carboxylate 1838-39-7 C12H21NO4 详情 详情
(IV) 66743 ethyl 3-oxoquinuclidine-2-carboxylate   C10H15NO3 详情 详情
(V) 66744 quinuclidin-3-one hydrochloride   C7H11NO.HCl 详情 详情
(VI) 66745 quinuclidin-3-ol   C7H13NO 详情 详情
(VII) 66746 quinuclidin-3-yl acetate   C9H15NO2 详情 详情
(VIII) 16152 (3R)-1-azabicyclo[2.2.2]octan-3-ol; (R)-(-)-Quinuclidinol 42437-96-7 C7H13NO 详情 详情
Extended Information